L V Demidov - JoVE Visualize

Showing results (11-20 of 23) with videos related to

Pageof 3

Sort By:

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|December 18, 2007

[Adoptive immunotherapy of malignancies]I Zh Shubina, A G Bliumenberg, S M Volkov, et al.

Genetika|November 1, 1995

[Clinico-genetic aspects of cutaneous melanoma. I. Incidence, familial study, genetic heterogeneity]R F Gar'kavtseva, T S Sitnikova, T P Kazubskaia, et al.

Arkhiv Patologii|September 8, 2016

[Impact of СD8/FoxP3 T lymphocyte ratio in the peritumoral area of primary cutaneous melanoma on the prognosis of the disease]Ya A Bozhchenko, Ya V Vishnevskaya, I A Pokataev, et al.

Cancer Genetics and Cytogenetics|January 1, 1992

Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomasO I Sokova, O P Kirichenko, A F Mukeria, et al.

Voprosy Onkologii|January 1, 1991

[Cytoplasmic receptors of steroid hormones and clinico-morphological characteristics of skin melanoma]E S Gershteĭn, B B Taĭlakov, K D Smirnova, et al.

Voprosy Virusologii|December 16, 2004

[Search for HHV-8 associated diseases reservoir and spread paths of HHV-8 in Russia]V E Gurtsevich, E L Kadyrova, V A Chernova, et al.

Genetika|November 1, 1995

[Clinico-genetic aspects of cutaneous melanoma. II. Interconnection and pathogenetic commonality with dysplastic nevus syndrome]G Iu Kharkevich, T P Kazubskaia, R K Agapova, et al.

Molekuliarnaia Biologiia|December 30, 2015

[ Spectrum of oncogene mutations is different in melanoma subtypes]N N Mazurenko, I V Tsyganova, A A Lushnikova, et al.

Bulletin of Experimental Biology and Medicine|April 17, 2010

Use of recombinant interleukin-2 for intrapleural therapy of tumor-associated pleurisyK S Titov, M V Kiselevskii, L V Demidov, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2014

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazineJ-J Grob, M M Amonkar, S Martin-Algarra, et al.

Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:

Pageof 3

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|December 18, 2007

[Adoptive immunotherapy of malignancies]I Zh Shubina, A G Bliumenberg, S M Volkov, et al.

Genetika|November 1, 1995

[Clinico-genetic aspects of cutaneous melanoma. I. Incidence, familial study, genetic heterogeneity]R F Gar'kavtseva, T S Sitnikova, T P Kazubskaia, et al.

Arkhiv Patologii|September 8, 2016

[Impact of СD8/FoxP3 T lymphocyte ratio in the peritumoral area of primary cutaneous melanoma on the prognosis of the disease]Ya A Bozhchenko, Ya V Vishnevskaya, I A Pokataev, et al.

Cancer Genetics and Cytogenetics|January 1, 1992

Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomasO I Sokova, O P Kirichenko, A F Mukeria, et al.

Voprosy Onkologii|January 1, 1991

[Cytoplasmic receptors of steroid hormones and clinico-morphological characteristics of skin melanoma]E S Gershteĭn, B B Taĭlakov, K D Smirnova, et al.

Voprosy Virusologii|December 16, 2004

[Search for HHV-8 associated diseases reservoir and spread paths of HHV-8 in Russia]V E Gurtsevich, E L Kadyrova, V A Chernova, et al.

Genetika|November 1, 1995

[Clinico-genetic aspects of cutaneous melanoma. II. Interconnection and pathogenetic commonality with dysplastic nevus syndrome]G Iu Kharkevich, T P Kazubskaia, R K Agapova, et al.

Molekuliarnaia Biologiia|December 30, 2015

[ Spectrum of oncogene mutations is different in melanoma subtypes]N N Mazurenko, I V Tsyganova, A A Lushnikova, et al.

Bulletin of Experimental Biology and Medicine|April 17, 2010

Use of recombinant interleukin-2 for intrapleural therapy of tumor-associated pleurisyK S Titov, M V Kiselevskii, L V Demidov, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2014

Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazineJ-J Grob, M M Amonkar, S Martin-Algarra, et al.

Pageof 3